Advertisement
Screener

NEUROPACE, INC. (NPCE) Graph

NPCE Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $22.83M; Cost of revenue $3.92M; Research and development $6.90M; Selling, general and administrative (m).
  • 2026-03-31: Revenue $22.07M; Cost of revenue $4.02M; Research and development $7.19M; Selling, general and administrative (m).
  • 2025-12-31: Revenue $26.59M*; Cost of revenue $6.01M*; Research and development $7.03M*; Selling, general and administrative (m).
  • 2025-09-30: Revenue $27.35M; Cost of revenue $6.19M; Research and development $6.58M; Selling, general and administrative (m).

Geography

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

NPCE revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Non Us$400.00KRevenue$22.83MCost of revenue$3.92MGross profit$18.91MOperating expenses$24.05MOperating income-$5.14MOther income, net-$41.00KResearch & development$6.90MNet income-$6.20M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$22.83M$3.92M$6.90M(m)$24.05M(m)-$6.20M
2026-03-31$22.07M$4.02M$7.19M(m)$23.62M$0.00-$6.69M
2025-12-31$26.59M*$6.01M*$7.03M*(m)$22.34M*$0.00*-$2.73M*
2025-09-30$27.35M$6.19M$6.58M(m)$23.77M$0.00-$3.50M
2025-06-30$19.50M$3.29M$6.84M(m)$24.40M$0.00-$8.65M
2025-03-31$22.52M$5.18M$7.44M$15.05M$22.49M$0.00-$6.59M
2024-12-31(m)(m)(m)$13.79M*(m)(m)(m)
2024-09-30$21.06M$5.64M$5.75M$13.91M$19.66M$0.00-$5.45M
2024-06-30$19.26M$5.12M$6.07M$14.30M$20.36M$0.00-$7.51M
2024-03-31$18.12M$4.78M$5.78M$15.10M$20.89M$0.00-$8.93M
2023-09-30$16.43M$4.19M$4.79M$13.39M$18.18M$0.00-$7.26M
2023-06-30$16.51M$4.54M$5.34M$14.48M$19.83M$0.00-$9.12M
2023-03-31$14.47M$4.10M$5.26M$13.43M$18.69M$0.00-$10.38M
2022-09-30$11.16M$3.19M$5.61M$12.55M$18.16M$0.00-$11.79M
2022-06-30$10.20M$2.73M$5.67M$12.77M$18.44M$0.00-$12.69M
2022-03-31$11.37M$3.12M$5.58M$12.44M$18.02M$0.00-$11.46M
2021-09-30$10.34M$2.83M$4.33M$9.42M$13.75M$0.00-$8.08M
2021-06-30$12.63M$3.27M$4.44M$9.53M$13.96M$0.00-$8.49M
2021-03-31$11.22M$2.72M$4.10M$8.27M$12.37M$0.00-$8.81M
2020-09-30$12.77M$3.20M$3.69M$7.05M$10.74M$0.00-$4.13M
2020-06-30$7.64M$2.22M$3.25M$5.62M$8.87M$0.00-$8.79M
2020-03-31$9.97M$2.92M$4.83M$7.68M$12.52M$0.00-$6.74M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$44.83M$7.91M$14.09M(m)$47.66M(m)-$12.89M
2025-06-30$37.82M$6.48M$14.29M(m)$46.29M$0.00-$15.24M
2024-06-30$37.38M$9.90M$11.85M$29.40M$41.25M$0.00-$16.44M
2023-06-30$30.98M$8.64M$10.61M$27.91M$38.52M$0.00-$19.50M
2022-06-30$21.57M$5.85M$11.25M$25.21M$36.46M$0.00-$24.15M
2021-06-30$23.85M$6.00M$8.54M$17.79M$26.33M$0.00-$17.30M
2020-06-30$17.61M$5.14M$8.09M$13.30M$21.38M$0.00-$15.53M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-09-30$73.40M$16.76M$20.86M(m)$71.21M$0.00-$18.74M
2024-09-30$58.44M$15.54M$17.60M$43.31M$60.91M$0.00-$21.89M
2023-09-30$47.41M$12.83M$15.40M$41.30M$56.70M$0.00-$26.76M
2022-09-30$32.73M$9.04M$16.86M$37.77M$54.63M$0.00-$35.94M
2021-09-30$34.19M$8.83M$12.87M$27.21M$40.08M$0.00-$25.39M
2020-09-30$30.39M$8.33M$11.78M$20.35M$32.12M$0.00-$19.66M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-12-31$99.99M$22.77M$27.89M(m)$93.56M$0.00-$21.46M
2024-12-31$79.91M$20.82M$23.65M$57.10M$80.76M(m)-$27.14M
2023-12-31$65.42M$17.30M$20.78M$54.52M$75.30M(m)-$32.96M
2022-12-31$45.52M$13.03M$21.95M$51.34M$73.29M(m)-$47.08M
2021-12-31$45.18M$11.75M$18.21M$38.96M$57.17M(m)-$36.08M
2020-12-31$41.14M$10.87M$15.70M$27.63M$43.32M(m)-$24.28M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sight Sciences, Inc. (SGHT)United States$0.478B-9.95
ClearPoint Neuro, Inc. (CLPT)United States$0.446B-15.74
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16
CERUS CORP (CERS)United States$0.525B-86.40
CARLSMED, INC. (CARL)United States$0.405B
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33
Orthofix Medical Inc. (OFIX)$0.373B
SS Innovations International, Inc. (SSII)$0.589B-64.06
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B
Orchestra BioMed Holdings, Inc. (OBIO)United States$0.356B-4.39